Dynamic EMT: a multi‐tool for tumor progression

S Brabletz, H Schuhwerk, T Brabletz… - The EMBO journal, 2021 - embopress.org
The process of epithelial–mesenchymal transition (EMT) is fundamental for embryonic
morphogenesis. Cells undergoing it lose epithelial characteristics and integrity, acquire …

Control of stem cell renewal and fate by YAP and TAZ

JH Driskill, D Pan - Nature Reviews Molecular Cell Biology, 2023 - nature.com
Complex physiological processes control whether stem cells self-renew, differentiate or
remain quiescent. Two decades of research have placed the Hippo pathway, a highly …

An allosteric pan-TEAD inhibitor blocks oncogenic YAP/TAZ signaling and overcomes KRAS G12C inhibitor resistance

TJ Hagenbeek, JR Zbieg, M Hafner, R Mroue… - Nature Cancer, 2023 - nature.com
The Hippo pathway is a key growth control pathway that is conserved across species. The
downstream effectors of the Hippo pathway, YAP (Yes-associated protein) and TAZ …

The molecular biology of pancreatic adenocarcinoma: translational challenges and clinical perspectives

S Wang, Y Zheng, F Yang, L Zhu, XQ Zhu… - Signal transduction and …, 2021 - nature.com
Pancreatic cancer is an increasingly common cause of cancer mortality with a tight
correspondence between disease mortality and incidence. Furthermore, it is usually …

Towards targeting of shared mechanisms of cancer metastasis and therapy resistance

F Weiss, D Lauffenburger, P Friedl - Nature Reviews Cancer, 2022 - nature.com
Resistance to therapeutic treatment and metastatic progression jointly determine a fatal
outcome of cancer. Cancer metastasis and therapeutic resistance are traditionally studied as …

The Hippo pathway in cancer: YAP/TAZ and TEAD as therapeutic targets in cancer

R Cunningham, CG Hansen - Clinical Science, 2022 - portlandpress.com
Tumorigenesis is a highly complex process, involving many interrelated and cross-acting
signalling pathways. One such pathway that has garnered much attention in the field of …

Targeting the Hippo pathway in cancer, fibrosis, wound healing and regenerative medicine

A Dey, X Varelas, KL Guan - Nature reviews Drug discovery, 2020 - nature.com
The Hippo pathway is an evolutionarily conserved signalling pathway with key roles in
organ development, epithelial homeostasis, tissue regeneration, wound healing and …

Expected and unexpected effects after systemic inhibition of Hippo transcriptional output in cancer

I Baroja, NC Kyriakidis, G Halder, IM Moya - Nature Communications, 2024 - nature.com
Hyperactivation of YAP/TAZ, the Hippo pathway downstream effectors, is common in human
cancer. The requirement of YAP/TAZ for cancer cell survival in preclinical models, prompted …

Mechanisms of resistance to oncogenic KRAS inhibition in pancreatic cancer

J Dilly, MT Hoffman, L Abbassi, Z Li, F Paradiso… - Cancer …, 2024 - aacrjournals.org
KRAS inhibitors demonstrate clinical efficacy in pancreatic ductal adenocarcinoma (PDAC);
however, resistance is common. Among patients with KRAS G12C-mutant PDAC treated …

EMT transition states during tumor progression and metastasis

I Pastushenko, C Blanpain - Trends in cell biology, 2019 - cell.com
Epithelial–mesenchymal transition (EMT) is a process in which epithelial cells acquire
mesenchymal features. In cancer, EMT is associated with tumor initiation, invasion …